Listen in as rheumatology experts Alexis Ogdie, MD, MSCE, and Julia Swafford, PA-C, DFAAPA, discuss emerging therapies and strategies in managing patients with axial spondyloarthritis or psoriatic arthritis, including:

  • The current treatment landscape (eg, small molecules, biologics)
  • Risk factors to consider when prescribing JAK inhibitors
  • Key considerations regarding comorbidities, especially in addressing depression, anxiety, or social ideation 
  • Nonpharmacologic options to improve treatment outcomes
  • Shared decision-making strategies to enhance patients’ investment in their care

Presenter:

Alexis Ogdie, MD, MSCE
Director, Penn Psoriatic Arthritis and Spondylarthritis Program
Director, Penn Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania
Philadelphia, Pennsylvania

Julia Swafford, PA-C, DFAAPA
President of SPAR
Bronson Battle Creek Rheumatology Specialists
Battle Creek, Michigan

Link to full program: 
bit.ly/4gkTzSv


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Practicing Clinicians Exchange. Innehållet i podden är skapat av Practicing Clinicians Exchange och inte av, eller tillsammans med, Poddtoppen.